| 发明名称 |
LUNG CANCER ADJUVANT THERAPY |
| 摘要 |
The present invention includes compositions and methods for the treatment of cancer comprising an antineoplastic drug and an inhibitor of chromosome maintenance region 1 (CRM1) protein expression or activity, wherein the inhibitor of CRM1 enhances the anti-neoplastic effect of the antineoplastic drug. |
| 申请公布号 |
WO2015183983(A1) |
申请公布日期 |
2015.12.03 |
| 申请号 |
WO2015US32714 |
申请日期 |
2015.05.27 |
| 申请人 |
TEXAS TECH UNIVERSITY SYSTEM |
发明人 |
GAO, WEIMIN |
| 分类号 |
A61K31/282;A61K31/366;A61P35/00 |
主分类号 |
A61K31/282 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
